Literature DB >> 26514138

Nonintubated transareolar single-port thoracic sympathicotomy with a needle scope in a series of 85 male patients.

Jian-Feng Chen1, Jian-Bo Lin1, Yuan-Rong Tu2, Min Lin1, Xu Li1, Fan-Cai Lai1, Quan Du1, Yuan-Da Dai3.   

Abstract

BACKGROUND: Traditional endoscopic thoracic sympathicotomy is usually performed through an axillary incision with 5-mm thoracoscope under general anesthesia with endotrachea intubation. Nonintubated transareolar single-port thoracic sympathicotomy with a needle scope has rarely been attempted. The objective of this study is to evaluate the feasibility and safety of this minimally invasive technique in managing primary palmar hyperhidrosis (PPH).
METHODS: From May 2012 to May 2014, a total of 85 male patients with severe PPH underwent transareolar single-port thoracic sympathicotomy by use of a 2-mm needle scope under total intravenous anesthesia without endotrachea intubation.
RESULTS: All procedures were successfully performed with a mean operating time of 13.5 min. The palms of all patients became dry and warm as soon as the sympathetic chain was cut off. There were no sore throat, and all the patients regained consciousness rapidly after surgery. Eighty-two patients (96.5 %) were discharged from the hospital on the first postoperative day. The postoperative complications were minor, and no patients developed Horner's syndrome. At 6 months postoperatively, there is no obvious surgical scar on the chest wall, and none of the patients complained about postoperative pain. Compensatory sweating appeared in 31 patients. No recurrent symptoms were observed in our study. One-year follow-up revealed an excellent cosmetic result and degree of satisfaction.
CONCLUSIONS: Nonintubated transareolar single-port needlescopic thoracic sympathicotomy is a safe, effective and minimally invasive therapeutic procedure, which can be performed in routine clinical practice for male PPH patients.

Entities:  

Keywords:  Areolar approach; Intravenous anesthesia; Needlescopic surgery; Primary palmar hyperhidrosis; Single-port sympathicotomy

Mesh:

Year:  2015        PMID: 26514138     DOI: 10.1007/s00464-015-4628-5

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  36 in total

1.  Endoscopic thoracic sympathectomy for palmar hyperhidrosis: efficacy of T2 and T3 ganglion resection.

Authors:  Motoki Yano; Masanobu Kiriyama; Ichiro Fukai; Hidefumi Sasaki; Yoshihiro Kobayashi; Kotaro Mizuno; Hiroshi Haneda; Eriko Suzuki; Katsuhiko Endo; Yoshitaka Fujii
Journal:  Surgery       Date:  2005-07       Impact factor: 3.982

2.  Endoscopic thoracic sympathectomy for palmar hyperhidrosis: a randomized control trial comparing T3 and T2-4 ablation.

Authors:  Xu Li; Yuan-Rong Tu; Min Lin; Fan-Cai Lai; Jian-Feng Chen; Zhu-Jian Dai
Journal:  Ann Thorac Surg       Date:  2008-05       Impact factor: 4.330

3.  Palmar hyperhidrosis and its surgical treatment: a report of 100 cases.

Authors:  R Adar; A Kurchin; A Zweig; M Mozes
Journal:  Ann Surg       Date:  1977-07       Impact factor: 12.969

4.  Video assisted thoracoscopic re-sympathetic surgery in the treatment of re-sweating hyperhidrosis.

Authors:  Do Hyung Kim; Hyo Chae Paik; Doo Yun Lee
Journal:  Eur J Cardiothorac Surg       Date:  2005-05       Impact factor: 4.191

5.  Quality of life and outcomes after nonintubated versus intubated video-thoracoscopic pleurodesis for malignant pleural effusion: comparison by a case-matched study.

Authors:  Tommaso Claudio Mineo; Francesco Sellitri; Federico Tacconi; Vincenzo Ambrogi
Journal:  J Palliat Med       Date:  2014-04-28       Impact factor: 2.947

6.  Severity of compensatory sweating after thoracoscopic sympathectomy.

Authors:  Peter B Licht; Hans K Pilegaard
Journal:  Ann Thorac Surg       Date:  2004-08       Impact factor: 4.330

7.  Transumbilical thoracic sympathectomy with an ultrathin flexible endoscope in a series of 38 patients.

Authors:  Li-Huan Zhu; Wen Wang; Shengsheng Yang; Dazhou Li; Zhijian Zhang; Shengping Chen; Xianjin Cheng; Long Chen; Weisheng Chen
Journal:  Surg Endosc       Date:  2013-01-26       Impact factor: 4.584

Review 8.  Anaesthesia for thoracoscopic surgery.

Authors:  Ian D Conacher
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2002-03

9.  Thoracoscopic sympathectomy for hyperhidrosis: indications and results.

Authors:  Neelan Doolabh; Shannon Horswell; Mary Williams; Lynne Huber; Syma Prince; Dan M Meyer; Michael J Mack
Journal:  Ann Thorac Surg       Date:  2004-02       Impact factor: 4.330

10.  Surgical treatment of primary palmar hyperhidrosis: a prospective randomized study comparing T3 and T4 sympathicotomy.

Authors:  Yanguo Liu; Jie Yang; Jun Liu; Fan Yang; Guanchao Jiang; Jianfeng Li; Yuqing Huang; Jun Wang
Journal:  Eur J Cardiothorac Surg       Date:  2009-01-21       Impact factor: 4.191

View more
  4 in total

Review 1.  Optimal targeting of sympathetic chain levels for treatment of palmar hyperhidrosis: an updated systematic review.

Authors:  Hai-Wei Sang; Guo-Liang Li; Peng Xiong; Ming-Chuang Zhu; Min Zhu
Journal:  Surg Endosc       Date:  2017-04-07       Impact factor: 4.584

2.  Feasibility of thoracoscopic pulmonary bullectomy using a transareolar approach for treatment of primary spontaneous pneumothorax.

Authors:  Tomohiro Yazawa; Hitoshi Igai; Fumi Ohsawa; Ryohei Yoshikawa; Natsumi Matsuura; Mitsuhiro Kamiyoshihara
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

3.  Transareolar single-port endoscopic thoracic sympathectomy with a flexible endoscope for primary palmar hyperhidrosis: a prospective randomized controlled trial.

Authors:  Jian-Bo Lin; Ming-Qiang Kang; Jian-Feng Chen; Quan Du; Xu Li; Fan-Cai Lai; Yuan-Rong Tu
Journal:  Ann Transl Med       Date:  2020-12

4.  The Anesthesiologist's Perspective Regarding Non-intubated Thoracic Surgery: A Scoping Review.

Authors:  Giulio Luca Rosboch; Paraskevas Lyberis; Edoardo Ceraolo; Eleonora Balzani; Martina Cedrone; Federico Piccioni; Enrico Ruffini; Luca Brazzi; Francesco Guerrera
Journal:  Front Surg       Date:  2022-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.